ZCM
NEO icon

Zebra Capital Management’s NeoGenomics NEO Stock Holding History

Zebra Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-19,667
Closed -$402K – 503
2019
Q1 		$402K Buy
19,667
+816
+4% +$14.2K 0.21% 157
2018
Q4 		$238K Buy
18,851
+7,608
+68% +$113K 0.15% 278
2018
Q3 		$173K Buy
+11,243
New +$155K 0.08% 389

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Zebra Capital Management's NEO Position: Q2 2019 in Review

Zebra Capital Management sold out of NeoGenomics (NEO) in Q2 2019, closing a stake of 19,667 shares — an estimated $402K sold.

Zebra Capital Management first reported a position in NEO in Q3 2018 and held it in 3 quarters. The position peaked at $402K in Q1 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q2 2019.

  • Zebra Capital Management reported no remaining NeoGenomics position as of Q2 2019 after selling out during the quarter.
  • Zebra Capital Management sold 19,667 NeoGenomics shares in Q2 2019, an estimated $402K.
  • Zebra Capital Management first reported a position in NeoGenomics in Q3 2018 and held it in 3 quarters.
  • Zebra Capital Management's NeoGenomics position peaked at $402K in Q1 2019.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2019.

Based on Zebra Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.